Evidence map›Paper›PMID 26348891›Full record

Trial reportBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child.

Christina K Ullrich, Angie Mae Rodday, Kristin Bingen, Mary Jo Kupst, Sunita K Patel, Karen L Syrjala, Lynnette L Harris, Christopher J Recklitis, Lisa Schwartz, Stella Davies and 4 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Christina K UllrichDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts. Electronic address: christina_ullrich@dfci.harvard.edu.
Angie Mae RoddayInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.
Kristin BingenDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Mary Jo KupstDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Sunita K PatelDepartments of Population Sciences and Supportive Care Medicine, City of Hope Medical Center, Duarte, California.
Karen L SyrjalaBiobehavioral Sciences Department, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Lynnette L HarrisDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas.
Christopher J RecklitisDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
Lisa SchwartzDivision of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania.
Stella DaviesDivision of Bone Marrow Transplant and Immune Deficiency Cincinnati Children's Hospital Medical Center Cincinnati, Ohio.
Eva C GuinanDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
Grace ChangDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Joanne WolfeDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
Susan K ParsonsInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts; Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts.

Funding

Internet Studies to Enhance Long Term Survivorship after Hematologic MalignancyR01CA160684 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SYRJALA, KAREN LESLIE · 2011 to 2015
$3.4M
HSCT-CHESS to Enhance Hematopoietic Transplant RecoveryR01CA119196 · NCI · TUFTS MEDICAL CENTER · PI PARSONS, SUSAN KENYON · 2006 to 2010
$3.1M
Symptom Distress in Pediatric Hematopoietic Stem Cell Transplant RecipientsK23HL107452 · NHLBI · DANA-FARBER CANCER INST · PI ULLRICH, CHRISTINA K · 2011 to 2015
$713k
NCI NIH HHS 5R01 CA119196NCI NIH HHS R01 CA119196NCI NIH HHS R01 CA160684NHLBI NIH HHS 1K23HL107452-01NHLBI NIH HHS K23 HL107452
6 · The paper itself

Abstract

Pediatric hematopoietic stem cell transplantation (HSCT) offers cure for high-risk malignancies and other conditions, but carries a risk of complications. Parental outlook regarding their child's transplantation course and future health has been largely unexplored. This report presents the Parent Outlook Scale, describes its properties, and examines the outlook of parents embarking on their child's transplantation course and the associated variables. Parents of children scheduled to undergo HSCT (n = 363) at 8 US transplantation centers completed the Parent Outlook Scale, comprising 4 items assessing frequency of the parent's thoughts about the potential difficulty of the child's transplantation (Transplant Difficult subscale) and worsened health (Health Worse subscale). Item responses were rated on a 5-point Likert scale (ranging from "none" to "all of the time") and, along with scale/subscale scores, transformed to 100-point scales, with higher scores connoting greater thought frequency. Psychometrics were explored. Multivariable models identified personal and clinical characteristics associated with scale and subscale scores. The Parent Outlook Scale (α = 0.75) and subscales were found to have sound psychometric properties. Factor loading supported the single scale with 2 subscales representing distinct aspects of overall outlook. Mean scores (Parent Outlook, 52.5 ± 21.7; Transplant Difficult, 64.4 ± 25.6; Health Worse, 40.7 ± 25.7) revealed variability within and across scale/subscales. Significantly different mean subscale scores (P < .001) indicated more frequent Transplant Difficult thoughts than Health Worse thoughts. Clinical factors (solid tumor diagnosis and unrelated donor transplant) and a parent factor (worse emotional functioning) were associated with higher scale and subscale scores. Our findings show that the outlook of parents embarking on their child's HSCT course is varied and not solely a product of clinical factors readily apparent to clinicians. Referring and transplantation clinicians should create opportunities to explore with parents their perspectives and concerns before and during the course of HSCT.

Indexed as

AdolescentAdultChildChild, PreschoolFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedNeoplasmsParentsProspective StudiesPsychometricsHealth-related quality of lifeHematopoietic stem cell transplantationPediatricsSupportive care

Identifiers

PMID26348891
PMCPMC4706486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.